Covered recipient · General Payments record
MARK GUDESBLATT
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$279,658.97
- Reported across 786 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $917.35 | 20 |
| Travel and Lodging | $50.00 | 1 |
| Education | $16.72 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $246.89 | 8 |
| Biogen, Inc. | $131.13 | 3 |
| JAZZ PHARMACEUTICALS INC. | $127.34 | 1 |
| TG THERAPEUTICS, INC. | $114.28 | 1 |
| ACADIA Pharmaceuticals Inc | $104.94 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $93.45 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $42.74 | 2 |
| EMD Serono, Inc. | $38.34 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.21 | 1 |
| PFIZER INC. | $26.04 | 1 |
| Lilly USA, LLC | $24.71 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $104.94 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147971723 | CMS |
| Amgen Inc. | $18.77 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590554 | CMS |
| Amgen Inc. | $10.28 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590556 | CMS |
| Amgen Inc. | $8.89 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590558 | CMS |
| Amgen Inc. | $16.62 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590560 | CMS |
| Amgen Inc. | $10.61 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590562 | CMS |
| Amgen Inc. | $24.22 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590564 | CMS |
| Amgen Inc. | $143.59 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590566 | CMS |
| Amgen Inc. | $13.91 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111590568 | CMS |
| Biogen, Inc. | $21.93 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104871476 | CMS |
| Biogen, Inc. | $81.23 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104812033 | CMS |
| Biogen, Inc. | $27.97 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104857738 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $26.02 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144445766 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 11/26/2024 | Education | Undisputed | 01/23/2026 | 1144445768 | CMS |
| EMD Serono, Inc. | $38.34 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120265247 | CMS |
| JAZZ PHARMACEUTICALS INC. | $127.34 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150219067 | CMS |
| Lilly USA, LLC | $24.71 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135156839 | CMS |
| Novartis Pharmaceuticals Corporation | $34.21 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086784211 | CMS |
| PFIZER INC. | $26.04 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131009897 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.00 | 07/26/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1137564478 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.45 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137564482 | CMS |
| TG Therapeutics, Inc. | $114.28 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136874171 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.